Hirao, M., Yamasaki, N., Oze, H., Ebina, K., Nampei, A., Kawato, Y., Shi, K., Yoshikawa, H., Nishimoto, N. and Hashimoto, J. (2012) Serum Level of Oxidative Stress Marker Is Dramatically Low in Patients with Rheumatoid Arthritis Treated with Tocilizumab. Rheumatology International, 32, 4041-4045.
https://doi.org/10.1007/s00296-011-2135-0
-
TITLE:
Tocilizumab Significantly Decreases Reactive Oxygen Species Level in Patients with Rheumatoid Arthritis
AUTHORS:
Naoki Kondo, Katsumitsu Arai, Takahiro Netsu, Tomotake Kanai, Hiroshige Sano, Go Okumura, Yasufumi Kijima, Junichi Fujisawa, Naoto Endo
KEYWORDS:
Tocilizumab, Rheumatoid Arthritis, Reactive Oxygen Species, Disease Activity Score 28
JOURNAL NAME:
Open Journal of Rheumatology and Autoimmune Diseases,
Vol.7 No.1,
January
11,
2017
ABSTRACT:
To determine the effect of tocilizumab (TCZ) on reactive oxygen species (ROS) in 11 patients with rheumatoid arthritis (RA), reactive oxygen metabolites (d-ROM) were measured using a Free Radical Elective Evaluator. The Disease Activity Score (DAS28) and matrix metalloproteinase-3 (MMP-3) level were also evaluated. d-ROM measured 392 ± 110 Carratelli units [U. CARR] on initiation of TCZ, and significantly decreased to 237 ± 82, 248 ± 88, and 226 ± 91 U.CARR after 3, 6, and 12 months, respectively (p
Related Articles:
Kinetic Characterization of Na,K-ATPase Inhibition by the Acetaminophen Metabolite N-Acetylbenzoquinoneimine
Jeff B. Helms, Lauren P. Saunders, Jamie Meyer, Charles J. Costa, Eric Plowman, Nick Williford, Matthew Corbitt, Jeremy P. Holden, Craig Gatto
DOI:
10.4236/ojmip.2015.51001
3,485 Downloads 3,945 Views Citations
Pub. Date:
February
3,
2015
